Sentinel node biopsy in 70 unselected patients with breast cancer: Increased feasibility by using 10 mCi radiocolloid in combination with a blue dye tracer

European Journal of Surgical Oncology

Volumn 25, Issue 1, 1999, Pages 24-29

  Van der Ent, F W C ^a   Kengen, R A M ^a   Van der Pol, H A G ^a   Hoofwijk, A G M ^a  

^a Sittard Geleen Heerlen   (Netherlands)

Author keywords

Breast cancer; Lymphatic mapping; Sentinel node biopsy

Indexed keywords

DISULFINE BLUE; NANOCOLL TC 99M; TRACER; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER STAGING; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; HUMAN; INTRADERMAL DRUG ADMINISTRATION; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0033082178     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.1998.0594     Document Type: Article

References (23)

1. JAMA. 254:1985;3461-3463.
2. Rosen PP, Lesser ML, Kinne DW, Beattie E.J. Discontinuous or "skip" metastases in breast carcinoma. Analysis of 1228 axillary dissections. Ann Surg. 197:1983;276-283.
3. Krag DN, Weaver DL, Alex JC, Fairbank J.T. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 2:1993;335-340.
4. Ivens D, Hoe AL, Podd TJ, Hamilton CR, Taylor I, Royle G.T. Assessment of morbidity from complete axillary dissection. Br J Cancer. 66:1992;136-138.
5. Guiliano AE, Kirgan DM, Guenther JM, Morton D.L. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 220:1994;391-401.
6. Giuliano AE, Sentinel lymphadenectomy in primary breast carcinoma: an alternative to routine axillary dissection. J Surg Oncol. 62:1996;75-77.
7. Uren RF, Howman-Giles RB, Thompson JF,. Mammary lymphoscintigraphy in breast cancer. J Nucl Med. 36:1995;1775-1780.
8. Collet GJ, Pijpers R, Hoekstra OS, Boom R, Meijer S. Sentinel node procedure in breast cancer using Tc 99 m-colloidal albumin. Eur J Surg Oncol. 22:1996;430.
9. Albertini JJ, Lyman GH, Cox C,. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA. 276:1996;1818-1822.
10. Pijpers R, Meijer S, Hoekstra OS,. Impact of lymphoscintigraphy on sentinel node identification with technetium-99 m-colloidal albumin in breast cancer. J Nucl Med. 38:1997;366-368.
11. Veronesi U, Paganelli G, Galinberti V,. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 349:1997;1864-1867.
12. Pijpers R., Dignum P., Meijer S. De schildwachtklier-procedure: stralingshygiënische aspecten van een nieuwe chirurgische techniek. Tijdschr Nucl Geneeskd. 19:1997;144-147.
13. Borgstein PJ, Meijer S, Pijpers R. Intradermal blue dye to identify sentinel lymph node in breast cancer. Lancet. 349:1997;1668-1669.
14. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol. 15:1997;2345-2350.
15. Rodier JF, Janser J.C. Surgical technical details improving sentinel node identification in breast cancer. Oncology Rep. 4:1997;281-283.
16. Roumen RMH, Valkenburg JGM, Geuskens L.M. Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oncol. 23:1997;495-502.
17. Reintgen D, Joseph E., Lyman GH,. The role of selective lymphadenectomy in breast cancer. Cancer Control: JMCC. 4:1997;211-219.
18. Borgstein PJ, Pijpers R, Comans E,. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg. 186:1998;275-283.
19. Koller M, Barsuk D, Zippel S,. Sentinel lymph node involvement - a predictor for axillary node status with breast cancer - has the time come. Eur J Surg Oncol. 24:1998;166-168.
20. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne D.L. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg. 222:1995;394-401.
21. Lacour J, Le M, Caceres E, Koszarowski T, Veronesi U, Hill C. Radical mastectomy versus radical mastectomy plus internal mammary dissection. Ten year results of an international cooperative trial in breast cancer. Cancer. 51:1983;1941-1943.
22. van de Velde CJH, Leer JWH. De betekenis van de regionale lymfeklierstations bij de metastasering van het mamma carcinoom en implicaties voor behandeling. Ned Tijdschr Geneeskd. 129:1985;1865-1870.
23. Dowlatshahi K, Ming F, Snider HC, Fahim A.H. Lymph node micrometastases from breast carcinoma. Reviewing the dilemma. Cancer. 80:1997;1188-1197.